2nd Quarter - Report

THE OB-C GROUP, LLC for EMERGENT BIOSOLUTIONS INC.

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY 2018 Appropriations-provisions related to development, acquisition and stockpiling of medical countermeasures. No specific bill number;Matters related to Provisions related to development, acquisition and stockpiling of medical countermeasures for the US Government.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Homeland Security HOM

No specific bill number;Matters relating to Department of Homeland Security Appropriations with provisions related to development, acquisition and stockpiling of bio defense vaccines.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Defense DEF

No specific bill numbers;Matters relating to FY 2019 Appropriations-provisions related to development, acquisition and stockpiling of medical countermeasures. No specific bill number;Matters related to Provisions related to development, acquisition and stockpiling of medical countermeasures for the US Government.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Disaster Planning/Emergencies DIS

No specific bill numbers;Matters relating to FY2019 Appropriations-provisions related to development, acquisition and stockpiling of medical countermeasures. No specific bill number;Matters related to Provisions related to development, acquisition and stockpiling of medical countermeasures for the US Government.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.